The finding that bacopasides block AQP1 has been successfully translated into a novel treatment in vivo, with recent work showing that cardiac hypertrophy induced by AQP1-mediated fluxes of hydrogen peroxide H2O2 was prevented by systemic treatment with bacopaside II [146]. The gene discussed is AQP1; the disease is cardiac hypertrophy.